[Pj-42] Japanese Poster Session 42
Neuroimmunity (multiple sclerosis 1)

[Pj-42-6] Safety and effectiveness of natalizumab in a real-world clinical setting in Japan

^○Kazumasa Yokoyama¹, Ryusuke Sato², Haruki Makioka², Michihiro Kanda², Naoto Matsuda², Takahiko Saida³ (1.Department of Neurology, Juntendo University School of Medicine, 2.Biogen Japan Ltd., 3.Kyoto Min-iren Central Hospital, Kansai Multiple Sclerosis Center)